Literature DB >> 19195825

Fifteen-year to 19-year follow-up of the Insall-Burstein-1 total knee arthroplasty.

Ayesha R Abdeen1, Stacy R Collen, Stacy B Collen, Kelly G Vince.   

Abstract

This represents a 15-year to 19-year follow-up of 100 Insall-Burstein-I posterior-stabilized knee prostheses implanted in 86 patients from 1986 to 1989 and originally reported at 10 to 12 years (Thadani et al, 2000). In the original cohort, 6 failures occurred by 10 years. At 15 to 19 years, 55 patients (66 knees) had died; 18 patients were followed with clinical examination and radiographs, and 11 by telephone; 3 knees in 2 patients were lost. There were no new failures or additional surgeries from 10 to 19 years. Three knees exhibited osteolytic lesions. No case required revision due to symptomatic osteolysis or polyethylene wear. Using revision as end point, survival was 92.4% at 19 years. In summary, the prosthesis is likely to outlive the patients when classic indications for age and activity are respected. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19195825     DOI: 10.1016/j.arth.2009.01.009

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  14 in total

1.  Long-term survivorship and failure modes of unicompartmental knee arthroplasty.

Authors:  Jared R H Foran; Nicholas M Brown; Craig J Della Valle; Richard A Berger; Jorge O Galante
Journal:  Clin Orthop Relat Res       Date:  2013-01       Impact factor: 4.176

2.  Onlay tibial implants appear to provide superior clinical results in robotic unicompartmental knee arthroplasty.

Authors:  Brian P Gladnick; Denis Nam; Saker Khamaisy; Sophia Paul; Andrew D Pearle
Journal:  HSS J       Date:  2014-11-15

3.  Unicompartmental versus total knee arthroplasty database analysis: is there a winner?

Authors:  Matthew C Lyons; Steven J MacDonald; Lyndsay E Somerville; Douglas D Naudie; Richard W McCalden
Journal:  Clin Orthop Relat Res       Date:  2012-01       Impact factor: 4.176

Review 4.  How to treat a tibial post fracture in total knee arthroplasty? A systematic review.

Authors:  Paul F Lachiewicz
Journal:  Clin Orthop Relat Res       Date:  2010-10-21       Impact factor: 4.176

5.  The Effect of Working Time and Application Technique on Cement Penetration into a Tibial Model.

Authors:  Thomas L Schmicker; Akshay Goel; Sarah Davis; Syed Ali Sina Adil; Ali Oliashirazi; Matthew Bullock
Journal:  Arthroplast Today       Date:  2022-07-09

6.  Kinematic analysis of anterior cruciate ligament reconstruction in total knee arthroplasty.

Authors:  Hua-Wei Liu; Ming Ni; Guo-Qiang Zhang; Xiang Li; Hui Chen; Qiang Zhang; Wei Chai; Yong-Gang Zhou; Ji-Ying Chen; Yu-Liang Liu; Cheng-Kung Cheng; Yan Wang
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

7.  Aseptic tibial debonding as a cause of early failure in a modern total knee arthroplasty design.

Authors:  Diren Arsoy; Mark W Pagnano; David G Lewallen; Arlen D Hanssen; Rafael J Sierra
Journal:  Clin Orthop Relat Res       Date:  2013-01       Impact factor: 4.176

Review 8.  Implant survival of 3rd-condyle and post-cam posterior-stabilised total knee arthroplasty are comparable at follow-up > 10 years: a systematic review.

Authors:  David H Dejour; Jacobus H Müller; Mo Saffarini; Michel Timoteo; Pierre Chambat; Gerard Deschamps; Michel P Bonnin
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2021-03-04       Impact factor: 4.342

9.  How long does a knee replacement last? A systematic review and meta-analysis of case series and national registry reports with more than 15 years of follow-up.

Authors:  Jonathan T Evans; Robert W Walker; Jonathan P Evans; Ashley W Blom; Adrian Sayers; Michael R Whitehouse
Journal:  Lancet       Date:  2019-02-14       Impact factor: 79.321

10.  Is there a difference in joint line restoration in revision Total knee arthroplasty according to prosthesis type?

Authors:  JuHong Lee; SungIl Wang; KiBum Kim
Journal:  BMC Musculoskelet Disord       Date:  2018-10-20       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.